1. Home
  2. LTRN vs NXPL Comparison

LTRN vs NXPL Comparison

Compare LTRN & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

HOLD

Current Price

$3.34

Market Cap

49.9M

Sector

Health Care

ML Signal

HOLD

Logo NextPlat Corp

NXPL

NextPlat Corp

HOLD

Current Price

$0.61

Market Cap

25.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
LTRN
NXPL
Founded
2013
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
49.9M
25.6M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
LTRN
NXPL
Price
$3.34
$0.61
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
66.3K
176.0K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$57,151,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.55
$0.43
52 Week High
$6.12
$2.30

Technical Indicators

Market Signals
Indicator
LTRN
NXPL
Relative Strength Index (RSI) 44.11 44.90
Support Level $3.19 $0.58
Resistance Level $3.68 $0.70
Average True Range (ATR) 0.26 0.06
MACD -0.01 0.00
Stochastic Oscillator 18.52 18.50

Price Performance

Historical Comparison
LTRN
NXPL

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

Share on Social Networks: